Decoy Therapeutics Inc. Stock Issued During Period, Shares, Conversion of Convertible Securities
Decoy Therapeutics Inc. (DCOY) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 355.68 thousand shares for the 1-month period ending 2018-10-31, per its 10-K filed 2020-03-23.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2020-03-23
- 2018-10-31: Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month 355.68K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month |
|---|---|
| 2018-10-31 | 355.68K shares 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |